 |
Chimeric group B adenovirus (11p/3) with deletions in the E3 and E4 regions |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| EU Market Approval | EU |
| EU Designation Date | 2015-02-12 00:00:00 |
| Sponsor | PsiOxus Therapeutics Ltd |
| |
Chimeric group B adenovirus (11p/3) with deletions in the E3 and E4 regions |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| EU Market Approval | EU |
| EU Designation Date | 2015-02-12 00:00:00 |
| Sponsor | PsiOxus Therapeutics Ltd |